These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2323732)

  • 41. Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features.
    Skinner MA; Swain M; Simmons R; McCarty KS; Sullivan DC; Iglehart JD
    Ann Surg; 1988 Aug; 208(2):203-8. PubMed ID: 3401063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.
    Armes JE; Galbraith C; Gray J; Taylor K
    Pathology; 2017 Apr; 49(3):267-270. PubMed ID: 28238415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The histopathology of non-palpable breast lesions detected by clinical mammography.
    Skjørten FJ; Skaane P; Jacobsen U; Kaaresen R; Haaheim LL
    Eur J Surg Oncol; 1990 Dec; 16(6):475-80. PubMed ID: 2253791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the surgical pathologist in the examination of the non-palpable breast lesion.
    Leong AS; Mower GA
    Pathology; 1992 Oct; 24(4):264-71. PubMed ID: 1289767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Detection of microcalcifications by high-resolution B-mode sonography in patients with BI-RADS 4a lesions].
    Stöblen F; Landt S; Köninger A; Hecktor J; Kimmig R; Kümmel S
    Gynakol Geburtshilfliche Rundsch; 2009; 49(4):292-8. PubMed ID: 20530944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can mammographic findings help discriminate between atypical ductal hyperplasia and ductal carcinoma in situ after needle core biopsy?
    Hoang JK; Hill P; Cawson JN
    Breast; 2008 Jun; 17(3):282-8. PubMed ID: 18063369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ.
    Clauser P; Marino MA; Baltzer PA; Bazzocchi M; Zuiani C
    Expert Rev Anticancer Ther; 2016; 16(3):335-46. PubMed ID: 26780850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Morphometry by analysis of microcalcifications and histopathological diagnosis: a new approach to the diagnosis of impalpable lesions of the breast detected by mammography].
    Charpin C; Garcia S
    Bull Acad Natl Med; 1995 Oct; 179(7):1517-31; discussion 1532-7. PubMed ID: 8556425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium oxalate crystals (Weddellite) within the secretions of ductal carcinoma in situ--a rare phenomenon.
    Singh N; Theaker JM
    J Clin Pathol; 1999 Feb; 52(2):145-6. PubMed ID: 10396244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies].
    Wedegärtner U; Otto U; Buitrago-Tellez C; Bremerich J; Oertli D; Torhorst J; Bongartz G
    Rofo; 2001 Mar; 173(3):224-8. PubMed ID: 11293864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonpalpable breast microcalcifications: frequency, management, and results of incisional biopsy.
    Homer MJ
    Radiology; 1992 Nov; 185(2):411-3. PubMed ID: 1410347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sonographic detection and sonographically guided biopsy of breast microcalcifications.
    Soo MS; Baker JA; Rosen EL
    AJR Am J Roentgenol; 2003 Apr; 180(4):941-8. PubMed ID: 12646433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Image cytometric classification of premalignant breast disease in fine needle aspirates.
    King EB; Chew KL; Duarte L; Hom JD; Mayall BH; Miller TR; Petrakis NL
    Cancer; 1988 Jul; 62(1):114-24. PubMed ID: 3383110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical hyperplasia of the breast: mammographic appearance and histologic correlation.
    Helvie MA; Hessler C; Frank TS; Ikeda DM
    Radiology; 1991 Jun; 179(3):759-64. PubMed ID: 2027988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stereotaxic needle localization and biopsy of occult breast lesions: first year's experience.
    Elliott RL; Haynes AE; Bolin JA; Boagni EM; Head JF
    Am Surg; 1992 Feb; 58(2):126-31. PubMed ID: 1550304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereotaxic localization and core needle biopsy of nonpalpable breast lesions: two-year follow-up of a prospective study.
    Head JF; Haynes AE; Elliott MC; Elliott RL
    Am Surg; 1996 Dec; 62(12):1018-23. PubMed ID: 8955240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereotactic core breast biopsy of malignant calcifications: diagnostic yield of cores with and cores without calcifications on specimen radiographs.
    Margolin FR; Kaufman L; Jacobs RP; Denny SR; Schrumpf JD
    Radiology; 2004 Oct; 233(1):251-4. PubMed ID: 15333764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathologic correlation in mammographically directed breast biopsies.
    Symonds DA; Copeland BE; Drane A; Kaplan GN; Graham RR
    Arch Pathol Lab Med; 1992 Jan; 116(1):28-32. PubMed ID: 1734830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of spring-loaded and vacuum-assisted techniques for stereotactic breast biopsy of impalpable microcalcification lesions: experience at Chang Gung Memorial Hospital at Linkou.
    Huang PC; Cheung YC; Lo YF; Chen SC; Chao TC; Ueng SH; Hsueh S; Chang MH; Ng SH
    Chang Gung Med J; 2011; 34(1):75-83. PubMed ID: 21392477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical application of localized biopsy on breast microcalcification].
    Wang J; Wang X; Liang JW; Gao JD; Bai XF
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):881-2. PubMed ID: 17953830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.